MoneyWorks4Me

Gland Pharma informs about analyst meet

15 Dec 2021 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting with the Company as on 17th December 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1761.95
Dr. Reddys Labs. 1217.00
Cipla 1310.80
Lupin 1955.70
Zydus Lifesciences 1114.20
View more..